Martingale Asset Management L P bought a new stake in shares of Exelon Co. (NASDAQ:EXC - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 421,337 shares of the company's stock, valued at approximately $15,859,000.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Quantinno Capital Management LP lifted its position in shares of Exelon by 51.2% during the 3rd quarter. Quantinno Capital Management LP now owns 75,759 shares of the company's stock valued at $3,072,000 after buying an additional 25,656 shares in the last quarter. Stifel Financial Corp lifted its holdings in Exelon by 2.4% during the third quarter. Stifel Financial Corp now owns 120,169 shares of the company's stock valued at $4,873,000 after purchasing an additional 2,827 shares in the last quarter. Kovitz Investment Group Partners LLC increased its stake in shares of Exelon by 110.9% in the third quarter. Kovitz Investment Group Partners LLC now owns 59,755 shares of the company's stock worth $2,423,000 after purchasing an additional 31,415 shares in the last quarter. XTX Topco Ltd purchased a new stake in shares of Exelon in the third quarter worth $204,000. Finally, Orion Portfolio Solutions LLC lifted its stake in shares of Exelon by 13.0% during the 3rd quarter. Orion Portfolio Solutions LLC now owns 9,118 shares of the company's stock valued at $370,000 after buying an additional 1,051 shares in the last quarter. 80.92% of the stock is owned by hedge funds and other institutional investors.
Exelon Trading Up 1.2 %
EXC traded up $0.53 during trading on Monday, reaching $46.53. The company had a trading volume of 3,067,172 shares, compared to its average volume of 7,159,502. The company has a quick ratio of 0.78, a current ratio of 0.87 and a debt-to-equity ratio of 1.61. Exelon Co. has a 52 week low of $34.01 and a 52 week high of $48.11. The stock has a market cap of $46.97 billion, a P/E ratio of 18.99, a PEG ratio of 2.86 and a beta of 0.39. The business has a 50 day simple moving average of $43.81 and a 200-day simple moving average of $40.59.
Exelon (NASDAQ:EXC - Get Free Report) last released its quarterly earnings results on Wednesday, February 12th. The company reported $0.64 EPS for the quarter, topping analysts' consensus estimates of $0.59 by $0.05. Exelon had a net margin of 10.68% and a return on equity of 9.52%. During the same quarter in the previous year, the firm posted $0.60 earnings per share. On average, equities analysts anticipate that Exelon Co. will post 2.64 EPS for the current fiscal year.
Exelon Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were issued a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 3.44%. This is an increase from Exelon's previous quarterly dividend of $0.38. The ex-dividend date was Monday, February 24th. Exelon's dividend payout ratio is presently 65.31%.
Insider Buying and Selling
In related news, EVP Colette D. Honorable sold 1,463 shares of the firm's stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $40.57, for a total value of $59,353.91. Following the transaction, the executive vice president now owns 2,271 shares of the company's stock, valued at $92,134.47. This trade represents a 39.18 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.10% of the stock is owned by corporate insiders.
Analysts Set New Price Targets
EXC has been the topic of a number of research analyst reports. Morgan Stanley boosted their price target on Exelon from $46.00 to $48.00 and gave the stock an "equal weight" rating in a report on Thursday, March 20th. Scotiabank boosted their target price on Exelon from $42.00 to $44.00 and gave the stock a "sector perform" rating in a research report on Thursday, February 13th. UBS Group raised their price target on Exelon from $45.00 to $47.00 and gave the company a "neutral" rating in a report on Friday, March 21st. Barclays increased their target price on Exelon from $42.00 to $48.00 and gave the company an "overweight" rating in a research report on Tuesday, February 25th. Finally, Evercore ISI upgraded shares of Exelon from an "in-line" rating to an "outperform" rating and boosted their price target for the stock from $43.00 to $44.00 in a research report on Tuesday, January 21st. Four analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat, Exelon has a consensus rating of "Moderate Buy" and an average target price of $45.13.
Read Our Latest Stock Report on Exelon
About Exelon
(
Free Report)
Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.
See Also

Before you consider Exelon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.
While Exelon currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.